Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,185.00-1.62%ETH$2,243.88-0.66%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
Stryker Corporation logo

NYSE · SYK

Stryker Corporation

Healthcare · Medical - Devices

$311.75

Down-$19.89 (-6.38%)

Updated Oct 30, 2026, 11:42 PM

SID Score

5.9/10

Composite research score

Smart Money

35/100

Bearish

Market cap
134.97B
P/E ratio
45.86
Dividend yield
1.08%
52-week range
$267.00 – $389.33
Volume
3.08M
Avg. volume
1.61M

Price performance · SYK

SYK price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 29, 2026

SYK closed at $311.75 after 21 trading sessions, up 14.21% for the selected period.

Last close
$311.75
Period change
+14.21%
Period low
$272.96
Period high
$311.75
Daily close
View OHLC price history
SYK OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 29, 2026$306.99$312.795$305.87$311.753.08M
Oct 28, 2026$297.52$305.29$297.00$304.002.33M
Oct 27, 2026$304.06$305.62$298.86$301.422.27M
Oct 26, 2026$305.43$307.47$301.78$306.131.89M
Oct 23, 2026$305.01$309.57$305.00$307.151.98M
Oct 22, 2026$299.80$309.68$299.36$307.082.8M
Oct 21, 2026$297.57$303.66$293.10$297.602.41M
Oct 20, 2026$302.29$305.03$298.932$304.403.17M
Oct 19, 2026$290.42$301.15$290.01$297.943.06M
Oct 16, 2026$295.89$299.6699$293.75$294.663.38M
Oct 15, 2026$287.00$293.99$286.55$293.233.12M
Oct 14, 2026$285.66$285.66$278.575$281.622.23M
Oct 13, 2026$284.23$287.45$278.62$282.552.07M
Oct 12, 2026$277.30$283.65$274.50$282.601.81M
Oct 9, 2026$277.01$281.58$276.53$277.331.48M
Oct 8, 2026$275.72$277.97$271.67$276.972.98M
Oct 7, 2026$280.16$281.96$274.45$275.401.92M
Oct 6, 2026$279.37$284.53$277.10$278.202.86M
Oct 5, 2026$275.50$286.09$275.00$285.223.33M
Oct 2, 2026$273.185$276.97$271.213$275.432M
Oct 1, 2026$275.60$278.51$271.341$272.962.46M

Latest SYK news

The latest Smart Investors Daily articles mentioning SYK.

Stock researchCompany · Overview

SYK research

Overview

Company profile and research snapshot.

Company profile

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$419.33
Implied upside
—
Analysts
20
SYK recent ratings
DateFirmRatingTarget
Oct 12, 2026BTIGBuy—
Oct 7, 2026Truist SecuritiesHold—
Oct 7, 2026BarclaysOverweight—
Sep 30, 2026StifelBuy—
Sep 22, 2026TD CowenHold—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 23, 2026

Stryker (SYK) Tests Its Valuation After Sonopet 3 Clearance

Stryker (SYK) just received 510(k) clearance from the U.S. Food and Drug Administration for Sonopet 3, a new ultrasonic bone and soft tissue removal platform shaped by extensive surgeon feedback. For context, Stryker’s recent 1 month share price return of 11.63% and 7 day move of 4.72% have come after a tougher patch, with the stock down 7.02% over 3 months and its 1 year total shareholder return declining 18.95%. Meanwhile, the 3 year and 5 year total shareholder returns of 22.32% and 20.59%...

Yahoo · Oct 23, 2026

Stryker (SYK) Stock May Trade At A Discount Despite FDA Clearance

Stryker has had a mixed run, with the share price up 22.3% over three years but still showing declines over the past year. This puts fresh focus on whether the current US$307.08 level lines up with the cash the business can generate. With new products, fresh partnerships and legal scrutiny all in play, the question for anyone looking at the stock is how those moving parts feed into its underlying cash flow story. The 22.3% gain over three years means a holder today is looking at a stock...

Yahoo · Oct 22, 2026

Global Laparoscope Market Size, Share, Trends, and Forecast for Rigid and Flexible Scopes, 2026-2032 | 4K, 3D, and Integrated Systems Fuel 6.3% CAGR to $1.3 Billion

The global laparoscope market is projected to grow from over $800 million in 2025 to nearly $1.3 billion by 2032, a new report finds, as integrated video, 4K and deflectable-tip designs drive upgrades, though tight hospital budgets and refurbished equipment weigh; Olympus, Karl Storz and Stryker are among the companies analyzed.Dublin, Oct. 22, 2026 (GLOBE NEWSWIRE) -- "Laparoscope Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: Rigid and Flexible Laparoscopes" has been add

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By